About Us

About Us

Superbiotics

Founded in 2019, Superbiotics’ mission is to develop innovative technologies and produce and formulate microbiotic solutions (blends and single strains) comprising live probiotic strains. The company also aims to valorize and patent processes or strains that have demonstrated a significant impact on human and animal health through the study of in vitro and ex vivo models, as well as in vivo in animals and humans. The identification of new physiological functionalities will enable the formulation of high value-added compounds.

Building on the expertise of Vésale Pharma, Superbiotics, owner of innovative probiotic strains, offers a wide range of probiotic products for digestive health, pediatrics, immunity and women’s well-being. Superbiotics’ commitment to quality is reflected in its rigorous selection of strains and patented INTELICAPS® encapsulation technology (property of Vésale Pharma), which guarantees the viability and efficacy of its probiotics.

With a global presence in Europe, the United States, Asia and the Middle East, Superbiotics is dedicated to improving health and well-being through innovative probiotic solutions.

2019

Creation

Creation of Superbiotics SRL

2019
2019

INTELICAPS®

Right of utilisation of the Vésale Pharma patented probiotic micro-encapsulation process (INTELICAPS®) that protects probiotics from humidity and heat. The process also protects bacteria from gastric acid and pancreatic juice without altering their functionality.

2019
2019

SuNup project

Wagralim cluster – ongoing project

Within the SuNup project, Superbiotics aims to replace the freeze-drying method of its Intelicaps process with faster, less energy-intensive alternatives. This objective also involves developing standardized micro-encapsulation methods suitable for the probiotic strains commercialized by the company.

2019
2022

PorcBiota project

Wagralim cluster – project completed in 2022

The main aim of the project was to develop innovative “synbiotics”, combining probiotics and prebiotics to protect piglets from birth to slaughter, thanks to the effect of synbiotics on the intestinal microbiota.
The positive effects of the Bf animalis lactis VES 002 strain have been demonstrated in preventing diarrhoea and improving growth in piglets.

2022
2023

Biotech4food project

Wagralim cluster – ongoing project

Within the Biotech4Food project, Superbiotics aims to enhance the efficiency of its manufacturing processes, particularly by replacing the freeze-drying method with less energy-intensive alternatives. Additionally, the project focuses on improving the stability and extending the shelf life of its microbiotic products. »

2023
2024

New building

Move out of the company in the Crealys Parc, Isnes, Belgium.

2024
2025

Pro Immunitum project

Wagralim cluster –  project awarded in January 2025

Studying the effects of a probiotic administered to pregnant women on infants’ immunity.

2025
2025

Continuous research

Superbiotics will continue its research regarding its proprietary strains and micro-encapsulation, focusing on 3 areas (women’s health, digestive health and paediatrics).

2025
R&D

R&D-based sales strategy

The strains marketed by Superbiotics have the following characteristics :

  • They contain live probiotics, i.e. probiotics with metabolic activity.
  • The strains are scientifically documented. For each strain, Superbiotics has compiled a monograph containing several relevant scientific publications demonstrating the benefits of these strains.
  • The strains are resistant to gastric acidity and bile salts, preserving their functional capacity right up to the intestinal site thanks to the Intelicaps encapsulation process.
  • They target various areas: digestive health, women’s health and immunity.
  • They are manufactured in the form of premixes: standardized or custom formulations (personalized/tailor made).
 
Our Team

Meet Our Team

Jehan LIENART​

Jehan LIENART​

CEO

Titouan VESTERS​

Titouan VESTERS​

COO

Jacqueline ABRASSART​

Jacqueline ABRASSART​

Finance & Admin Director​

Robin MATHYS​

Robin MATHYS​

Production Manager​

m

Annik SALVE​

Annik SALVE​

Laboratory Expert​

m

Adrien BERGER​

Adrien BERGER​

QA/RA Manager​ & Project Manager

France FANNES​

France FANNES​

Director of Public Funding & Research Contracting

Contact us

If you are an agent, distributor or want to promote our products internationally.